tipepidine has been researched along with Depressive Disorder, Major in 1 studies
tipepidine: RN given refers to parent cpd
Depressive Disorder, Major: Disorder in which five (or more) of the following symptoms have been present during the same 2-week period and represent a change from previous functioning; at least one of the symptoms is either (1) depressed mood or (2) loss of interest or pleasure. Symptoms include: depressed mood most of the day, nearly every daily; markedly diminished interest or pleasure in activities most of the day, nearly every day; significant weight loss when not dieting or weight gain; Insomnia or hypersomnia nearly every day; psychomotor agitation or retardation nearly every day; fatigue or loss of energy nearly every day; feelings of worthlessness or excessive or inappropriate guilt; diminished ability to think or concentrate, or indecisiveness, nearly every day; or recurrent thoughts of death, recurrent suicidal ideation without a specific plan, or a suicide attempt. (DSM-5)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hoobehfekr, S | 1 |
| Moghaddam, HS | 1 |
| Shalbafan, M | 1 |
| Hashemi, MG | 1 |
| Pirmoradi, MM | 1 |
| Sakenian, A | 1 |
| Poopak, A | 1 |
| Kashefinejad, S | 1 |
| Yarahmadi, M | 1 |
| Akhondzadeh, S | 1 |
1 trial available for tipepidine and Depressive Disorder, Major
| Article | Year |
|---|---|
Efficacy and safety of tipepidine as adjunctive therapy in major depressive disorder: A randomized, double-blind, placebo-controlled clinical trial.
Topics: Adult; Citalopram; Depressive Disorder, Major; Double-Blind Method; Drug Therapy, Combination; Femal | 2021 |